Stock
Ownership of a fraction of a corporation and the right to claim a share of the corporation's assets and profits equal to the amount of stock owned
US listed security
Listed on NASDAQ
US headquartered
Headquartered in Massachusetts, United States
Moderna Inc
$129.65
MRNA
After Hours:
$129.43
(-0.17%)-$0.22
Closed: Jan 15, 7:59:33 PM GMT-5 · USD · NASDAQ · Disclaimer

In the news

Financial performance
(USD)Q3 2020Year/year change
Revenue
157.91M826.38%
Net income
-233.64M-89.62%
Diluted EPS--
Net profit margin-147.96%79.53%
Operating income-235.12M-79.80%
Net change in cash-255.79M-1,258.14%
Cash on hand1.51B766.72%
Cost of revenue344.49M187.94%
About
Moderna is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts. It focuses on drug discovery, drug development, and vaccine technologies based exclusively on messenger RNA. Moderna's technology platform inserts synthetic nucleoside-modified mRNA into human cells. This mRNA then reprograms the cells to prompt immune responses. It is a novel technique, previously abandoned due to the side effects of inserting mRNA into cells. As of November 2020, the Moderna COVID-19 vaccine candidate, mRNA-1273, had shown preliminary evidence of 94% efficacy in preventing COVID-19 disease in a Phase III trial, with only minor flu-like side effects. This led to its submission for emergency use authorization in Europe, the United States, and Canada. On December 18, 2020, mRNA-1273 was issued an EUA in the United States. It was authorized for use in Canada on December 23, 2020, as well as in the European Union on January 6, 2021. Subsequently the mRNA-1273 was authorized in the United Kingdom on 8 January 2021. Wikipedia
Founded
Sep 2010
Employees
1,100

Key stats

Previous close
The last closing price
$129.72
Day range
The difference between the high and low prices over the past day
$126.58 - $133.29
Year range
The difference between the high and low prices over the past 52 weeks
$17.91 - $178.50
Market cap
A valuation method that multiplies the price of a company's stock by the total number of outstanding shares.
51.30B USD
Volume
The average number of shares traded each day over the past 30 days
26.12M
P/E ratio
The ratio of current share price to trailing twelve month EPS that signals if the price is high or low compared to other stocks
-
Dividend yield
The ratio of annual dividend to current share price that estimates the dividend return of a stock
-
Primary exchange
Listed exchange for this security
NASDAQ
About
Moderna is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts. It focuses on drug discovery, drug development, and vaccine technologies based exclusively on messenger RNA. Moderna's technology platform inserts synthetic nucleoside-modified mRNA into human cells. This mRNA then reprograms the cells to prompt immune responses. It is a novel technique, previously abandoned due to the side effects of inserting mRNA into cells. As of November 2020, the Moderna COVID-19 vaccine candidate, mRNA-1273, had shown preliminary evidence of 94% efficacy in preventing COVID-19 disease in a Phase III trial, with only minor flu-like side effects. This led to its submission for emergency use authorization in Europe, the United States, and Canada. On December 18, 2020, mRNA-1273 was issued an EUA in the United States. It was authorized for use in Canada on December 23, 2020, as well as in the European Union on January 6, 2021. Subsequently the mRNA-1273 was authorized in the United Kingdom on 8 January 2021. Wikipedia
Founded
Sep 2010
Employees
1,100

Discover more

You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more

People also search for

Search
Clear search
Close search
Google apps
Main menu